# Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

> **NCT00242983** · — · UNKNOWN · sponsor: **National Hospital Organization Kinki-chuo Chest Medical Center**

## Conditions studied

- Lung Cancer

## Interventions

- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00242983
- **Lead sponsor:** National Hospital Organization Kinki-chuo Chest Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242983, "Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00242983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*